Achieve more through your advocacy group with FDA’s help. Attending this workshop will enhance your understanding of how safe and effective drug therapies are approved, so you can advocate for your patients most effectively. This workshop can help you:
Registration is free and based on space availability, with priority given to early registrants. Persons interested in attending this public workshop must register by May 5, 2017, 6pm, EDT. Early registration is recommended. Seating is limited. If you need special accommodations due to a disability, please contact Chris Melton no later than May 1, 2017.
Click Here for additional meeting information on driving directions, transportation, parking, lodging, and more.
FOR FURTHER INFORMATION, CONTACT:
Chris Melton, Center for Drug Evaluation and Research, Food and Drug Administration